SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy (SWEAT) is trending as a comprehensive token analysis highlights recent scarcity boosts from token burns, its expanding utility as a multi-chain "universal gas token," and growing Web3 gaming features. The community actively discusses its unique "move-to-earn" model, expressing long-term optimism for its potential as a reward for physical activity.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL (GRAL) is sharply trending downwards following news that its NHS-Galleri cancer screening trial missed a primary endpoint, sparking intense community debate between investors who view the significant sell-off as an overreaction given other positive trial data and institutional backing, and those who foresee further declines due to the trial's failure.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending due to recent European approval for Anktiva, along with a significant distribution partnership, and a new US FDA submission, which has intensified community speculation about a looming short squeeze. Investors are actively discussing Dr. Pat's hints regarding massive global collaborations and Anktiva's potential for broader therapeutic applications, leading many to believe shorts are facing an unstoppable force.

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Tandem Diabetes Care Inc

Tandem Diabetes Care is a focus of discussion following its recent earnings, which generated mixed reactions among the community despite reported beats on some metrics, and is further driven by anticipation for its Control-IQ+ technology and strategic partnerships with Abbott. Many investors see the stock as undervalued given these developments and its efforts to enhance competitiveness in the evolving diabetes management sector.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is currently trending due to its deep integration with AI, highlighted by joining the NVIDIA Inception Program, and advancements in cross-chain capabilities via NEAR Intents. The community is actively discussing its robust fundamentals, recent tokenomics adjustments, and notable institutional interest, including Grayscale's S-1 filing for a NEAR Trust, driving accumulation debates among investors.

Pull your BankrWallet out of the Terminal and into the browser to use with Any Dapp, just like Metamask!

BankrWallet

BankrWallet ($BNKRW) is trending due to the recent launch of its open-source browser extension, offering MetaMask-like functionality within the Coinbase BASE ecosystem and live on Solana. The community is actively discussing its significant upside potential, with many urging early investment ahead of anticipated catalysts, including developer Apoorveth's upcoming discussions.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

KLAR is trending due to a steep stock decline following its Q4 earnings report, which showed a net loss driven by significantly increased credit loss provisions despite strong revenue growth. The community is divided, with many bears questioning the long-term viability and profitability of the "Buy Now, Pay Later" model, while some bulls contend the market is overreacting to accounting technicalities and see potential in the company's expanding user base and strategic partnerships.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings (CELH) is trending due to a significant after-hours surge following strong growth projections from its CEO at the CAGNY conference and positive commentary on Alani Nu integration during PepsiCo's earnings call. This has intensified community speculation of a future Pepsi acquisition, with bulls highlighting robust market share gains while others debate management's transparency and potential implications of Pepsi's increased board presence.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending after its Q4 earnings beat on revenue, EPS, and delivered record free cash flow. However, mixed reactions to 2026 gold production guidance, higher costs, and the dividend payout have fueled volatile discussions among investors, who are debating whether the dip presents a buying opportunity amid the strong gold market.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community eagerly anticipates the BLA resubmission for its Duchenne Muscular Dystrophy therapy, Deramiocel, expected by month-end after strong Phase 3 data. Investors are noting increasing institutional interest and potential regulatory shifts, positioning the stock as a compelling, undervalued biotech play amidst broader market rotations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


thanbai88

Thanbai 88